Virtu Financial LLC purchased a new stake in shares of Chemed Co. (NYSE:CHE – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 972 shares of the company’s stock, valued at approximately $515,000.
Several other large investors have also recently modified their holdings of CHE. CIBC Asset Management Inc increased its stake in Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after purchasing an additional 22 shares in the last quarter. CBIZ Investment Advisory Services LLC raised its holdings in Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after acquiring an additional 22 shares during the last quarter. EP Wealth Advisors LLC lifted its position in Chemed by 1.9% in the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after acquiring an additional 25 shares in the last quarter. Independent Advisor Alliance boosted its stake in Chemed by 1.1% during the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock valued at $1,207,000 after purchasing an additional 25 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Chemed by 7.1% in the 4th quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company’s stock worth $264,000 after purchasing an additional 33 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.
Insider Activity at Chemed
In other Chemed news, VP Brian C. Judkins purchased 145 shares of the company’s stock in a transaction dated Monday, December 30th. The shares were acquired at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. The trade was a 9.46 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares of the company’s stock, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by company insiders.
Chemed Stock Performance
Chemed Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s payout ratio is 10.05%.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on CHE shares. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada lifted their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th.
Get Our Latest Stock Report on Chemed
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
- Five stocks we like better than Chemed
- 3 Warren Buffett Stocks to Buy Now
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Technology Stocks Explained: Here’s What to Know About Tech
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.